Leading Japanese CRO CMIC Co., Ltd. Attains Highest Accreditation in Medidata Solutions, Inc.' ASPire to Win Partner Program

Published: Sep 28, 2009

NEW YORK & TOKYO--(BUSINESS WIRE)--Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced that CMIC, one of the largest contract research organizations (CROs) in Japan, has attained Rave Accredited Plus, the most advanced level in Medidata’s ASPire to Win® program for CROs and other service providers. With this accreditation, CMIC can now offer a comprehensive suite of services to implement and support Medidata Rave®, a leading platform for electronic clinical data capture, management and reporting, for a growing customer base in Japan, as well as across Asia.

Back to news